Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells. - Wikidata - wikimedia - TriplyDB

Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.

Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.

http://www.wikidata.org/entity/Q39110728

about

Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression.CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis.Cdk5 promotes DNA replication stress checkpoint activation through RPA-32 phosphorylation, and impacts on metastasis free survival in breast cancer patients.Cdk5r1 Overexpression Induces Primary β-Cell Proliferation.Evaluation and clinical significance of cyclin-dependent kinase5 expression in cervical lesions: a clinical research study in Guangxi, China Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway.STAT3 and metabolism: how many ways to use a single molecule?Analysis of STAT3 post-translational modifications (PTMs) in human prostate cancer with different Gleason Score.The Emerging Role of Cdk5 in Cancer Cdk5 links with DNA damage response and cancer.Cyclin-dependent kinase 5 represses Foxp3 gene expression and Treg development through specific phosphorylation of Stat3 at Serine 727 Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models.Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.CDK5 in oncology: recent advances and future prospects.Inhibition of Cdk5 induces cell death of tumor-initiating cells.

P2860

Q35171132-D3194982-F16D-438F-887A-46080FD9F917 Q35683173-302AE0D5-1A0F-4F4D-A943-0530FC52FFEE Q35735341-E85D85EE-4D5D-4FFC-BDE0-E9455297AC27 Q36405673-9FA7BAF1-BC16-464C-97DE-E3AA111EBF4D Q37089878-C0522765-F5EB-4A4A-AD5D-A467388149F8 Q37108420-14474E32-4D3A-4340-9F84-3DBFCB0883C8 Q38185622-5B257313-97AE-46FA-997C-5145AACCC29E Q38794210-102CF90F-9EA0-4C8F-9D7E-B6C020C76383 Q39029140-EEF009C0-9C44-401B-8566-08477F8471DE Q39176295-3FD8A025-993D-45B4-B3BD-0298256EE4F0 Q40710775-AA7251E9-7404-4D58-83A1-B1F2B8921CFB Q40989800-22C57D0C-6DF2-4DBE-B97C-4637BD7AE8D3 Q41017874-C6188164-E0AB-4187-B52E-56AA038C9C4D Q47873426-E669F4EC-3286-4FBF-8BAF-5A6DCA1C3DE6 Q50880834-20CF5252-3C21-4931-A122-CA5FD181797A

P2860

Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.

http://www.wikidata.org/entity/Q39110728

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Cyclin-dependent kinase 5 modu ...... TAT3 in prostate cancer cells.

@en

Cyclin-dependent kinase 5 modu ...... TAT3 in prostate cancer cells.

@nl

type

label

Cyclin-dependent kinase 5 modu ...... TAT3 in prostate cancer cells.

@en

Cyclin-dependent kinase 5 modu ...... TAT3 in prostate cancer cells.

@nl

prefLabel

Cyclin-dependent kinase 5 modu ...... TAT3 in prostate cancer cells.

@en

Cyclin-dependent kinase 5 modu ...... TAT3 in prostate cancer cells.

@nl

P1433

Q39110728-FC66460E-B626-4CB4-AF85-52D5D0BA4550

P1476

Q39110728-BB901D67-5C3D-4FA1-8A42-CE4960E8819B

P2093

Q39110728-027E04D0-B5D7-4AD9-9485-F5D55AA7F183

Q39110728-302C8B1F-653A-4C1A-ABF4-631695106AD3

Q39110728-73BE601C-BBF7-445D-ABE6-E648186FFAC0

Q39110728-78605038-25FD-4343-925B-E9B4CCBEE49E

Q39110728-8768DB02-E934-415A-98C6-EC19B4A9B9F2

Q39110728-95B309F4-736B-4C37-AECE-B6FE6A33AA67

Q39110728-A36DF3CF-63EE-42A0-958F-58385783F22E

Q39110728-D13918E6-ED71-49CB-BB89-B612B5623052

Q39110728-FAFF2667-0954-4562-B857-59DA409EDDF0

P2860

Q39110728-011E6C12-3F47-4646-AA2D-EFC38D514B0B

Q39110728-0A2A811A-67C3-462A-AA0F-B6297167B577

Q39110728-0EC355E9-4AF8-4892-8A58-40FD1932497A

Q39110728-13998CDF-BA62-447F-9B8C-F985173BD4DE

Q39110728-1D414D95-8552-4734-8205-31A62918D1E8

Q39110728-1E2B2681-1726-4E23-A203-5DEA0F8316F8

Q39110728-2993EB96-16BF-4341-88BD-7594CED03688

Q39110728-2A8B3417-6CC7-4175-A498-790FCE4723FD

Q39110728-3148EFE2-5AED-4D34-B4C8-A9F15D2219B6

Q39110728-36391C6A-A671-401E-9293-8CE5BB072974

P304

Q39110728-4D8677A8-A96C-4BE7-A478-382193689866

P31

Q39110728-B4E9FCA8-9EA0-4469-BD8B-6DBEFEB4DEFE

P356

Q39110728-B7752718-13F5-46C3-A00D-5754D70665F6

P433

Q39110728-6A27913E-6E02-40BA-94B0-E59058C74A51

P478

Q39110728-280600FF-325D-48C4-9085-A512404D9DF8

P577

Q39110728-6DAC789D-D3A5-4F0D-806B-405197A87C00

P5875

Q39110728-E95D0B91-E60A-4C03-AECD-25AA612185D6

P698

Q39110728-CF1E0CCB-56E5-4059-B7ED-DE31A21D51C8

P921

Q39110728-843014D1-7190-466A-961D-328DFFA26FD3

P356

AJPENDO.00615.2012

P1433

American Journal of Physiology - Endocrinology and Metabolism

P1476

Cyclin-dependent kinase 5 modu ...... TAT3 in prostate cancer cells.

@en

P2093

Eugene Lin

http://www.w3.org/2001/XMLSchema#string

Fu-Ning Hsu

http://www.w3.org/2001/XMLSchema#string

Ho Lin

http://www.w3.org/2001/XMLSchema#string

Jer-Tsong Hsieh

http://www.w3.org/2001/XMLSchema#string

Kuan-Chia Lin

http://www.w3.org/2001/XMLSchema#string

Mei-Chih Chen

http://www.w3.org/2001/XMLSchema#string

Ming-Ching Chiang

http://www.w3.org/2001/XMLSchema#string

Pei-Chi Li

http://www.w3.org/2001/XMLSchema#string

Yu-Ting Peng

http://www.w3.org/2001/XMLSchema#string

P2860

An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator

p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5

Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation

Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells

Cancer statistics, 2010

Serine phosphorylation and negative regulation of Stat3 by JNK

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells

STAT3 acts as a co-activator of glucocorticoid receptor signaling

Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells

P304

E975-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPENDO.00615.2012

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

305

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255951096

http://www.w3.org/2001/XMLSchema#string

P698

23941877

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation